Vivid Seats (SEAT) CEO Fey exercises RSUs, lifts Class A holdings to 185,428

Q: How many Vivid Seats (SEAT) shares does CEO Lawrence Fey hold after this Form 4?

After these transactions, Lawrence Fey directly holds 185,428 shares of Vivid Seats Class A common stock. This reflects shares received from the March 11, 2026 RSU exercises reported in the Form 4, with no open-market purchases or sales disclosed.

Q: Were the Vivid Seats (SEAT) CEO’s transactions open-market buys or sales?

The reported transactions are RSU exercises and vesting , not open-market buys or sales. All entries use transaction code M for derivative exercises, converting restricted stock units into Class A common shares as part of equity compensation vesting schedules.

Q: Does the Vivid Seats (SEAT) Form 4 show any remaining RSU expiration dates?

The footnotes state that the RSUs do not have an expiration date . Instead, they follow defined quarterly vesting schedules until their respective full vesting dates between March 11, 2026 and December 11, 2027 or March 11, 2028, depending on the specific grant.

Q: How many RSU exercises did the Vivid Seats (SEAT) CEO report in this filing?

The filing aggregates four derivative RSU exercises , totaling 111,337 underlying shares of Class A common stock. All transactions are coded as M for derivative exercises or conversions, with no reported gifts, tax withholdings, or restructuring transactions.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Vivid Seats Inc. Chief Executive Officer Lawrence Fey reported the vesting and exercise of restricted stock units into Class A common stock. On March 11, 2026, he exercised RSUs covering 111,337 shares of Class A common stock, increasing his direct holdings to 185,428 shares after the transactions.

The RSUs represent the right to receive one share of Class A common stock per unit and vest in scheduled quarterly installments. Different RSU grants reach full vesting on dates ranging from March 11, 2026 through March 11, 2028, with another grant fully vesting on December 11, 2027.

Insider Trade Summary

111,337 shares exercised/converted

Mixed 5 txns

Insider Fey Lawrence

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	1,192	$0.00	--
Exercise	Restricted Stock Units	4,038	$0.00	--
Exercise	Restricted Stock Units	29,655	$0.00	--
Exercise	Restricted Stock Units	76,452	$0.00	--
Exercise	Class A Common Stock	111,337	$0.00	--

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Class A Common Stock — 185,428 shares (Direct)

Footnotes (1)

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock. One-third of the RSUs vested on March 11, 2024. The remainder of the RSUs vested in equal quarterly installments such that fully vested on March 11, 2026. The RSUs do not have an expiration date. One-third of the RSUs vested on March 11, 2025. The remainder of the RSUs vest in equal quarterly installments such that they will be fully vested on March 11, 2027. The RSUs do not have an expiration date. One-third of the RSUs vested on March 11, 2026. The remainder of the RSUs vest in equal quarterly installments such that they will be fully vested on March 11, 2028. The RSUs do not have an expiration date. The RSUs began vesting in equal quarterly installments on March 11, 2026 such that they will be fully vested on December 11, 2027. The RSUs do not have an expiration date.

Form 4 Insider Transactions: What Each Field Means →

03/13/2026 - 04:15 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fey Lawrence

(Last)

(First)

(Middle)

C/O VIVID SEATS INC.

24 E. WASHINGTON ST., STE. 900

(Street)

CHICAGO

60602

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Vivid Seats Inc. [ SEAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	03/11/2026		M		111,337	A	⁽¹⁾	185,428	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	03/11/2026		M			1,192	⁽²⁾	⁽²⁾	Class A Common Stock	1,192	$0	0	D
Restricted Stock Units	⁽¹⁾	03/11/2026		M			4,038	⁽³⁾	⁽³⁾	Class A Common Stock	4,038	$0	16,152	D
Restricted Stock Units	⁽¹⁾	03/11/2026		M			29,655	⁽⁴⁾	⁽⁴⁾	Class A Common Stock	29,655	$0	59,313	D
Restricted Stock Units	⁽¹⁾	03/11/2026		M			76,452	⁽⁵⁾	⁽⁵⁾	Class A Common Stock	76,452	$0	535,168	D

Explanation of Responses:

1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock.

2. One-third of the RSUs vested on March 11, 2024. The remainder of the RSUs vested in equal quarterly installments such that fully vested on March 11, 2026. The RSUs do not have an expiration date.

3. One-third of the RSUs vested on March 11, 2025. The remainder of the RSUs vest in equal quarterly installments such that they will be fully vested on March 11, 2027. The RSUs do not have an expiration date.

4. One-third of the RSUs vested on March 11, 2026. The remainder of the RSUs vest in equal quarterly installments such that they will be fully vested on March 11, 2028. The RSUs do not have an expiration date.

5. The RSUs began vesting in equal quarterly installments on March 11, 2026 such that they will be fully vested on December 11, 2027. The RSUs do not have an expiration date.

	/s/ Lawrence Fey	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Vivid Seats (SEAT) CEO Lawrence Fey report?

Lawrence Fey reported RSU vesting and related exercises into Class A common stock. On March 11, 2026, RSUs covering 111,337 shares were converted, and his direct Class A common stock holdings increased to 185,428 shares following the transactions.

How many Vivid Seats (SEAT) shares does CEO Lawrence Fey hold after this Form 4?

After these transactions, Lawrence Fey directly holds 185,428 shares of Vivid Seats Class A common stock. This reflects shares received from the March 11, 2026 RSU exercises reported in the Form 4, with no open-market purchases or sales disclosed.

Were the Vivid Seats (SEAT) CEO’s transactions open-market buys or sales?

The reported transactions are RSU exercises and vesting, not open-market buys or sales. All entries use transaction code M for derivative exercises, converting restricted stock units into Class A common shares as part of equity compensation vesting schedules.

What are the vesting terms of the Vivid Seats (SEAT) RSUs reported by the CEO?

Each RSU represents one share of Class A common stock and vests in quarterly installments. Different grants fully vest on March 11, 2026, March 11, 2027, March 11, 2028, and December 11, 2027, according to the disclosed vesting footnotes.

Does the Vivid Seats (SEAT) Form 4 show any remaining RSU expiration dates?

The footnotes state that the RSUs do not have an expiration date. Instead, they follow defined quarterly vesting schedules until their respective full vesting dates between March 11, 2026 and December 11, 2027 or March 11, 2028, depending on the specific grant.

How many RSU exercises did the Vivid Seats (SEAT) CEO report in this filing?

The filing aggregates four derivative RSU exercises, totaling 111,337 underlying shares of Class A common stock. All transactions are coded as M for derivative exercises or conversions, with no reported gifts, tax withholdings, or restructuring transactions.